Michael Morale discusses how rising healthcare costs are straining the budgets in the European Union. Also, Kevin Schaefer reads from his review of the movie "The Upside", and how it portrays disability.

Michael Morale discusses how rising healthcare costs are straining the budgets in the European Union. Also, Kevin Schaefer reads from his review of the movie "The Upside", and how it portrays disability.

We discuss how scientists have developed a new method to evaluate nutritional status of children with SMA. Also, Michael Morale discusses the question that many individuals with SMA are trying to answer. This question involves just how far our muscles will take us in the future. We’re fortunate to have Spinraza as our first treatment option, and with the possible pending approval of ZOLGENSMA, this question may be answered in the not so distant future.

SMA News Today Community Editor Kevin Schaefer, and Forums & Miltimedia Director Michael Morale discuss tips on hiring a caregiver. Kevin has a caregiver that comes to his house a couple of times each day, and Michael has two live-in caregivers that are with him 24/7/365.

We discuss how scientists have developed a new method to evaluate nutritional status of children with SMA. Also, Michael Morale discusses the question that many individuals with SMA are trying to answer. This question involves just how far our muscles will take us in the future. We’re fortunate to have Spinraza as our first treatment option, and with the possible pending approval of ZOLGENSMA, this question may be answered in the not so distant future.

SMA News Today Community Editor Kevin Schaefer, and Forums & Miltimedia Director Michael Morale discuss tips on hiring a caregiver. Kevin has a caregiver that comes to his house a couple of times each day, and Michael has two live-in caregivers that are with him 24/7/365.

We discuss how ZOLGENSMA could be more cost-effective than Spinraza. Also, Kevin Schaefer discusses an article that he wrote for the SMA News Today website regarding how much each of us have changed over the past 10 years.

We discuss how ZOLGENSMA could be more cost-effective than Spinraza. Also, Kevin Schaefer discusses an article that he wrote for the SMA News Today website regarding how much each of us have changed over the past 10 years.

Michael Morale discusses the decision that was recently made where Poland agreed to reimburse the cost of Spinraza to treat SMA. Also, Kevin Schaefer discusses an article that he wrote for the SMA New Today forum regarding having your own space and living with SMA.

Michael Morale discusses the decision that was recently made where Poland agreed to reimburse the cost of Spinraza to treat SMA. Also, Kevin Schaefer discusses an article that he wrote for the SMA New Today forum regarding having your own space and living with SMA.